James Oleske

Q: What Schools Are Affiliated With James Oleske

James Oleske is affiliated with the following schools: University of Amsterdam, McGill University, Emory University, Rutgers University, University of Medicine and Dentistry of New Jersey, Columbia University, University of Detroit Mercy

James Oleske's AcademicInfluence.com Rankings

James Oleske

Philosophy

#7846

World Rank

#11113

Historical Rank

Logic

#6401

World Rank

#7916

Historical Rank

philosophy Degrees

Download Badge

Philosophy

James Oleske's Degrees

Doctorate Medicine University of Medicine and Dentistry of New Jersey
Masters Public Health Columbia University

Why Is James Oleske Influential?

(Suggest an Edit or Addition)

According to Wikipedia, James M. Oleske is an American pediatrician and HIV/AIDs researcher who is the emeritus François-Xavier Bagnoud Professor of Pediatrics at Rutgers New Jersey Medical School in Newark, New Jersey. He is best known for his pioneering work in identifying HIV/AIDS as a pediatric disease, and treating and researching it beginning in the 1980s. He published one of the first articles identifying HIV/AIDS in children in JAMA in 1983 and was a co-author of one of the articles by Robert Gallo and others identifying the virus in Science in 1984.

(See a Problem?)

James Oleske's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. (1984) (3532)
Guidelines for the use of antiretroviral agents in pediatric HIV infection (1998) (601)
Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America. (2004) (518)
EXPRESSION OF HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN (HIV-Ag) IN SERUM AND CEREBROSPINAL FLUID DURING ACUTE AND CHRONIC INFECTION (1986) (513)
Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1. (2001) (506)
Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. (2011) (504)
Tuberculosis as a manifestation of the acquired immunodeficiency syndrome (AIDS). (1986) (454)
Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams. (1999) (333)
Neurologic manifestations of human immunodeficiency virus infection in children. (1986) (319)
Declines in Mortality Rates and Changes in Causes of Death in HIV-1-Infected Children During the HAART Era (2010) (267)
Progressive encephalopathy in children with acquired immue deficiency syndrome (1985) (238)
Lymphocyte subsets in healthy children during the first 5 years of life. (1992) (221)
Primary care guidelines for the management of persons infected with human immunodeficiency virus: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. (2004) (190)
Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data. (2007) (181)
Detection of HTLV-III RNA in lungs of patients with AIDS and pulmonary involvement. (1986) (171)
Arteriopathy in children with acquired immune deficiency syndrome. (1987) (168)
A Polymorphism in the Regulatory Region of the CC-Chemokine Receptor 5 Gene Influences Perinatal Transmission of Human Immunodeficiency Virus Type 1 to African-American Infants (1999) (151)
Effects of one year of supplementation with zinc and other micronutrients on cellular immunity in the elderly. (1990) (150)
Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents (2009) (150)
In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children (2007) (139)
Elevated serum levels of tumor necrosis factor are associated with progressive encephalopathy in children with acquired immunodeficiency syndrome. (1989) (137)
Lack of tumors in infants with perinatal HIV-1 exposure and fetal/neonatal exposure to zidovudine. (1999) (134)
Expression of human immunodeficiency virus in cerebrospinal fluid of children with progressive encephalopathy (1987) (128)
Duration of ruptured membranes and vertical transmission of HIV-1: a meta-analysis from 15 prospective cohort studies (2001) (125)
Older children and adolescents living with perinatally acquired human immunodeficiency virus infection. (1995) (124)
Viral measurement by polymerase chain reaction-based assays in human immunodeficiency virus-infected infants. (1995) (120)
Population-based study of measles and measles immunization in human immunodeficiency virus-infected children. (1992) (114)
Primary lymphoma of the central nervous system in children with acquired immunodeficiency syndrome. (1988) (113)
Pathologic pulmonary findings in children with the acquired immunodeficiency syndrome: a study of ten cases. (1985) (111)
Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America. (2004) (111)
The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis (2018) (109)
Psychiatric hospitalizations among children and youths with human immunodeficiency virus infection. (2004) (107)
Human monocyte-macrophage-mediated antibody-dependent cytotoxicity to herpes simplex virus-infected cells. (1977) (106)
Quality of Life for Children and Adolescents: Impact of HIV Infection and Antiretroviral Treatment (2006) (105)
Zinc therapy of depressed cellular immunity in acrodermatitis enteropathica. Its correction. (1979) (103)
Two randomized controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus colds (1987) (101)
Sexual behaviors and procreational intentions of adolescents and young adults with perinatally acquired human immunodeficiency virus infection: experience of an urban tertiary center. (2006) (99)
Zinc and immunocompetence in the elderly: baseline data on zinc nutriture and immunity in unsupplemented subjects. (1987) (98)
Nucleoside exposure in the children of HIV-infected women receiving antiretroviral drugs: Absence of clear evidence for mitochondrial disease in children who died before 5 years of age in five United States cohorts (2000) (97)
Zinc and immunocompetence in elderly people: effects of zinc supplementation for 3 months. (1988) (95)
Thymus biopsy in children with acquired immunodeficiency syndrome. (1986) (89)
Delayed Onset of Pubertal Development in Children and Adolescents With Perinatally Acquired HIV Infection (2003) (86)
Birth Defects Among Children Born to Human Immunodeficiency Virus-Infected Women: Pediatric AIDS Clinical Trials Protocols 219 and 219C (2010) (84)
Suppression of immune function in growth hormone-deficient children during treatment with human growth hormone. (1986) (82)
Pathology of suspected acquired immune deficiency syndrome in children: a study of eight cases. (1984) (76)
Polyclonal polymorphic B‐cell lymphoproliferative disorder with prominent pulmonary involvement in children with acquired immune deficiency syndrome (1987) (76)
Prevalence of Elevated Cholesterol and Associated Risk Factors Among Perinatally HIV-Infected Children (4-19 years old) in Pediatric AIDS Clinical Trials Group 219C (2005) (74)
Long-term effects of protease-inhibitor-based combination therapy on CD4 T-cell recovery in HIV-1-infected children and adolescents (2003) (74)
Live virus vaccines in human immunodeficiency virus-infected children: a retrospective survey. (1988) (73)
Status of selected nutrients and progression of human immunodeficiency virus type 1 infection. (2000) (73)
Early viral suppression improves neurocognitive outcomes in HIV-infected children (2015) (73)
Safety, tolerance, and pharmacokinetics of systemic ribavirin in children with human immunodeficiency virus infection (1993) (72)
Protease Inhibitor Combination Therapy, Severity of Illness, and Quality of Life Among Children With Perinatally Acquired HIV-1 Infection (2005) (64)
Changing Trends in Complications and Mortality Rates Among US Youth and Young Adults With HIV Infection in the Era of Combination Antiretroviral Therapy. (2015) (64)
Acquired immunodeficiency syndrome-associated renal disease in children. (1988) (64)
PEDIATRIC AIDS CLINICAL TRIALS GROUP PROTOCOL 219 TEAM. EFFECT OF COMBINATION THERAPY INCLUDING PROTEASE INHIBITORS ON MORTALITY AMONG CHILDREN AND ADOLESCENTS INFECTED WITH HIV-1 (2001) (63)
Association of Hypercholesterolemia Incidence With Antiretroviral Treatment, Including Protease Inhibitors, Among Perinatally HIV-Infected Children (2008) (63)
All that palsies is not Bell's -the need to define Bell's palsy as an adverse event following immunization. (2007) (63)
Pathologic appraisal of the thymus gland in acquired immunodeficiency syndrome in children. A study of four cases and a review of the literature. (1985) (62)
Clinical and laboratory correlates of Pneumocystis carinii pneumonia in children infected with HIV. (1991) (61)
Impact of protease inhibitor-containing combination antiretroviral therapies on height and weight growth in HIV-infected children. (2001) (60)
Reconstitution of normal megakaryocytopoiesis and immunologic functions in Wiskott-Aldrich syndrome by marrow transplantation following myeloablation and immunosuppression with busulfan and cyclophosphamide (1981) (59)
Pubertal onset in children with perinatal HIV infection in the era of combination antiretroviral treatment (2013) (59)
Cutaneous manifestations of the acquired immunodeficiency syndrome in children. (1988) (58)
Immune deficiency syndrome in children. (1983) (56)
ELISPOT: a new approach to studying the dynamics of virus-immune system interaction for diagnosis and monitoring of HIV infection. (1989) (55)
Immunologic parameters in chronic fatigue syndrome, major depression, and multiple sclerosis. (1998) (55)
Effects of negative life events on immune suppression in children and youth infected with human immunodeficiency virus type 1. (2000) (52)
Dilated cardiomyopathy in children with acquired immunodeficiency syndrome: a pathologic study of five cases. (1988) (51)
Severe gastrointestinal involvement in children with the acquired immunodeficiency syndrome. (1987) (50)
Antiretroviral treatment in pediatric HIV infection in the United States: from clinical trials to clinical practice. (2005) (49)
The prevalence of pain in pediatric human immunodeficiency virus/acquired immunodeficiency syndrome as reported by participants in the Pediatric Late Outcomes Study (PACTG 219). (2002) (49)
Evidence against transmission of human T‐lymphotropic virus/lymphadenopathy‐associated virus (HTLV‐III/LAV) in families of children with the acquired immunodeficiency syndrome (1985) (49)
Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America. (2005) (49)
The impact of HAART on cardiomyopathy among children and adolescents perinatally infected with HIV-1 (2012) (49)
Effects of human growth hormone on immune functions: in vitro studies on cells of normal and growth hormone-deficient children. (1987) (46)
Malignancy in Perinatally Human Immunodeficiency Virus-Infected Children in the United States (2005) (46)
Neonatal infections: Case definition and guidelines for data collection, analysis, and presentation of immunisation safety data☆ (2016) (46)
Osteonecrosis of the hip (Legg-Calvé-Perthes disease) in human immunodeficiency virus-infected children. (2002) (44)
Association of Risk of Viremia, Immunosuppression, Serious Clinical Events, and Mortality With Increasing Age in Perinatally Human Immunodeficiency Virus–Infected Youth (2017) (44)
Incidence of Persistent Renal Dysfunction in Human Immunodeficiency Virus-Infected Children: Associations With the Use of Antiretrovirals, and Other Nephrotoxic Medications and Risk Factors (2009) (44)
Human polymorphonuclear leucocytes as mediators of antibody-dependent cellular cytotoxicity to herpes simplex virus-infected cells. (1977) (44)
Pulmonary lesions in children with the acquired immunodeficiency syndrome: a reappraisal based on data in additional cases and follow-up study of previously reported cases. (1986) (44)
Incidence of noninfectious conditions in perinatally HIV-infected children and adolescents in the HAART era. (2009) (43)
Lead poisoning--one approach to a problem that won't go away. (1997) (42)
Intravenous gamma globulin in progressive MS (1992) (42)
Guideline for collection, analysis and presentation of safety data in clinical trials of vaccines in pregnant women. (2016) (41)
Association of site-specific and participant-specific factors with retention of children in a long-term pediatric HIV cohort study. (2008) (38)
Reconstitution of normal megakaryocytopoiesis and immunologic functions in Wiskott-Aldrich syndrome by marrow transplantation following myeloablation and immunosuppression with busulfan and cyclophosphamide. (1981) (38)
Slow subcutaneous human intravenous immunoglobulin in the treatment of antibody immunodeficiency: use of an old method with a new product. (1998) (37)
Congenital microcephaly: Case definition & guidelines for data collection, analysis, and presentation of safety data after maternal immunisation (2017) (37)
Cutaneous acquired immunodeficiency syndrome-associated Kaposi's sarcoma in pediatric patients. (1990) (36)
Listeria monocytogenes Infection in Infants and Children (1977) (36)
Immunologic Aspects of Chronic Fatigue Syndrome (2004) (34)
Complications of peritonsillar abscess due to Fusobacterium necrophorum. (1976) (34)
Levodopa therapy improves motor function in HIV-infected children with extrapyramidal syndromes (1996) (33)
Possible mitochondrial dysfunction and its association with antiretroviral therapy use in children perinatally infected with HIV. (2010) (33)
A descriptive survey of pediatric human immunodeficiency virus-infected long-term survivors. (1997) (32)
Immunization site pain: case definition and guidelines for collection, analysis, and presentation of immunization safety data. (2012) (32)
Facial nerve palsy including Bell's palsy: Case definitions and guidelines for collection, analysis, and presentation of immunisation safety data. (2017) (32)
Pathology of opportunistic infections in children with acquired immune deficiency syndrome. (1986) (32)
In search of the Holy Grail. (1996) (32)
Natural killer cell function and interferon generation in patients with primary immunodeficiencies. (1986) (31)
Relationship between HTLV-III Neutralizing Antibody and Clinical Status of Pediatric Acquired Immunodeficiency Syndrome (AIDS) and AIDS-Related Complex Cases (1987) (29)
Hepatitis C prevalence in children with perinatal human immunodeficiency virus infection enrolled in a long-term follow-up protocol. (2004) (29)
Effects of antibiotics on polymorphonuclear leukocyte chemiluminescence and chemotaxis. (1983) (29)
Psychosocial impact of acquired immune deficiency syndrome. (1983) (29)
Morphologic findings in children with acquired immune deficiency syndrome: pathogenesis and clinical implications. (1990) (29)
Conduction system in children with acquired immunodeficiency syndrome. (1989) (29)
Do-not-resuscitate orders and/or hospice care, psychological health, and quality of life among children/adolescents with acquired immune deficiency syndrome. (2008) (29)
Blood Lead Levels of Children in Flint, Michigan: 2006‐2016 (2018) (27)
Acquired immune deficiency syndrome in children (1983) (26)
Inadvertent inoculation as an adverse event following exposure to vaccinia virus: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. (2007) (26)
The essential trace minerals, immunity, and progression of HIV-1 infection (2007) (25)
Negative Life Events: Risk to Health‐Related Quality of Life in Children and Youth With HIV Infection (2007) (25)
Chronic kidney disease associated with perinatal HIV infection in children and adolescents (2012) (24)
Neonatal seizures: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data (2019) (24)
Experiences with 118 Infants Born to Narcotic-using Mothers (1977) (23)
Antiretroviral therapy and medical management of the human immunodeficiency virus-infected child (1994) (21)
Decreased suppressor-inducer T lymphocytes in multiple sclerosis and other neurological diseases (1990) (21)
Elevated plasma zinc concentrations in renal dialysis patients. (1980) (20)
Persistent human immunodeficiency virus type 1 antigenemia in children correlates with disease progression. (1988) (20)
Transmission of hepatitis B in a classroom setting. (1980) (20)
Incomplete immune reconstitution despite virologic suppression in HIV-1 infected children and adolescents (2015) (20)
Immunologic disorders. (1989) (19)
Sexually Transmitted Infections in Youth With Controlled and Uncontrolled Human Immunodeficiency Virus Infection (2016) (19)
Reproductive health of adolescent girls perinatally infected with HIV. (2007) (17)
Continuum of palliative care: lessons from caring for children infected with HIV-1 (1999) (17)
Immune Deficiency Syndrome in Children-Reply (1983) (16)
Incidence of switching to second-line antiretroviral therapy and associated factors in children with HIV: an international cohort collaboration. (2019) (16)
Cytomegalovirus Urinary Shedding in HIV-infected Pregnant Women and Congenital Cytomegalovirus Infection (2017) (16)
Cutaneous manifestations of childhood acquired immunodeficiency syndrome and human immunodeficiency virus infection. (1995) (16)
On the historical origins of HIV-1 (MN) and (RF). (1992) (15)
Release of some trace metals from disposable coils during hemodialysis. (1982) (15)
Essential trace elements and progression and management of HIV infection. (2019) (15)
Fatigue: case definition and guidelines for collection, analysis, and presentation of immunization safety data. (2007) (15)
Treatment of HIV infected infants and children. (1988) (14)
Central Nervous System Vasculopathy in HIV-Infected Children Enrolled in the Pediatric AIDS Clinical Trials Group 219/219C Study. (2013) (14)
Immunologic aspects of chronic fatigue syndrome. Report on a Research Symposium convened by The CFIDS Association of America and co-sponsored by the US Centers for Disease Control and Prevention and the National Institutes of Health. (2004) (13)
T cell subsets and disease progression after total lymphoid irradiation in chronic progressive multiple sclerosis. (1988) (13)
Historical perspectives on the evolution in understanding the importance of nutritional care in pediatric HIV infection. (1996) (13)
A perspective on pediatric AIDS. (1988) (12)
Varicella does not appear to be a cofactor for human immunodeficiency virus infection in children. (1992) (11)
Enucleation of parotid lymphoepithelial cyst in patients who are human immunodeficiency virus positive. (1993) (11)
Congenital acquired immunodeficiency syndrome and congenital toxoplasmosis: pathologic support for a chronology of events. (1988) (11)
Blood Lead Concentrations of Children in the United States: A Comparison of States Using Two Very Large Databases (2017) (11)
Chronic fatigue syndrome in children and adolescents (2006) (11)
Determination of CD4 and CD8 lymphocyte subsets by a new alternative fluorescence immunoassay (1995) (11)
GB Virus C Infection in Children With Perinatal Human Immunodeficiency Virus Infection (2005) (10)
Radiographic patterns of PLH/LIP in HIV positive children (1993) (10)
A prospective study of the immune reconstitution inflammatory syndrome (IRIS) in HIV-infected children from high prevalence countries (2019) (10)
A selected review of breast-feeding recommendations (2006) (10)
The many needs of the HIV-infected child. (1994) (9)
Comparative trial of two dosages of zalcitabine in zidovudine-experienced children with advanced human immunodeficiency virus disease. Pediatric AIDS Clinical Trials Group. (1997) (9)
Effects of antimicrobials on host defence mechanism. (1984) (9)
The effect of total lymphoid irradiation and low-dose steroids on T lymphocyte populations in multiple sclerosis: correlation with clinical and MRI status (1997) (8)
Human immunodeficiency virus (HIV) infection in children. (1987) (8)
Nutrition in pediatric HIV infection: setting the research agenda. Working group session report: setting the clinical research agenda: domestic and international perspectives. (1996) (8)
The use of second-generation antipsychotics and the changes in physical growth in children and adolescents with perinatally acquired HIV. (2009) (8)
Human immunodeficiency virus testing of sexually abused children and their assailants (1990) (8)
Persistent non-gastrointestinal metabolic acidosis in pediatric HIV-1 infection (2003) (8)
Pain in children with HIV infection (1991) (7)
Analysis of blood lead levels of young children in Flint, Michigan before and during the 18-month switch to Flint River water (2019) (7)
Enzyme immunoassay for detection of human immunodeficiency virus-specific immunoglobulin A antibodies (1993) (7)
Impact of Medications Prescribed for Treatment of Attention-Deficit Hyperactivity Disorder on Physical Growth in Children and Adolescents With HIV (2009) (7)
Blood product acquired HIV infection in children. (1988) (7)
Randomized Controlled Trial of Feeding a Concentrated Formula to Infants Born to Women Infected by Human Immunodeficiency Virus (2009) (7)
When should we treat children with HIV? (2006) (7)
When a child with a chronic condition needs hospitalization. (1997) (6)
Acute aseptic arthritis: Case definition & guidelines for data collection, analysis, and presentation of immunisation safety data. (2019) (6)
The Evolution of Accommodation: Comparing the Unequal Treatment of Religious Objections to Interracial and Same-Sex Marriages (2015) (6)
Predictors of resolution and persistence of renal laboratory abnormalities in pediatric HIV infection (2014) (6)
Use of a modified quinacrine fluorochrome in the study of interphase cells for "Y bodies". (1971) (6)
Neoplastic diseases in children with acquired immunodeficiency syndrome. (1990) (6)
The maturation of an epidemic: update on pediatric HIV infection. (1993) (5)
The role of lung biopsy in children with perinatally acquired AIDS. (1998) (5)
Recommendations in pediatric antiretroviral therapy (2007) (5)
Review of recent guidelines for antiretroviral treatment of HIV-infected children. (2003) (5)
Enhancing supportive care and promoting quality of life: Clinical practice guidelines (1995) (5)
Long-term outcomes in infants born to HIV-infected women. (2003) (5)
Induction of autologous mixed lymphocyte culture responses by myelin basic protein-reactive T cell clones (1994) (5)
Stimulant Medications and Cognition, Behavior and Quality of Life in Children and Youth with HIV (2015) (5)
Medical management of children with HIV infection. (1990) (5)
Neurologic Manifestations of Human Immunodeficiency Virus Infection in Children (1986) (5)
Slit Ventricle Syndrome (2013) (5)
Enhancement of nitroblue tetrazolium dye reduction by leucocytes exposed to a factor released from sensitised lymphocytes. (1979) (4)
Flow cytometry in pediatric immunologic disorders (1991) (4)
HIV-2-Associated AIDS in the United States: The First Case (1989) (4)
The effects of acute infection on blood lead, copper, and zinc levels in children. (1975) (4)
Who cares for the human immunodeficiency virus-infected child? (1989) (4)
58 GROWTH HORMONE DEFICIENCY: INTERLEUKIN 2 (IL2) AND IMMUNE FUNCTION (1985) (4)
Effect of human immunodeficiency virus infection on serum beta2-microglobulin levels in pregnant women. (1999) (4)
Blood Lead Levels in Females of Childbearing Age in Flint, Michigan, and the Water Crisis. (2019) (4)
Juvenile papilloma of the larynx. (1971) (4)
Managing early HIV infection. Agency for Health Care Policy and Research. (1994) (4)
Ataxia telangiectasia with thrombasthenia, platelet dysfunction, and a chromosomal translocation. A monoclonal defect? (1981) (3)
Evaluation for late effects of In Utero (IU) ZDV exposure among uninfected infants bom to HIV+ women enrolled in ACTG 076 & 219 (1997) (3)
Infection in infants and children. (1977) (3)
The Impact and Perception of Cell Phone Usage in a Teaching Hospital Setting (2020) (3)
Potential Protective Effect of Sickle Cell Gene Allele on HIV Infection (2017) (3)
Lessons for Flint's Officials and Parents From Our 1970s Newark Lead Program. (2016) (3)
Federalism, Free Exercise, and Title VII: Reconsidering Reasonable Accommodation (2003) (3)
Regarding dietary calcium to reduce lead toxicity. (2009) (3)
I.v. immune globulin: efficacy and safety. (1987) (3)
This is no time to stop use of nevarapine to prevent mother-to-child transmission of HIV. (2006) (2)
300 Acquired immunodeficiency syndrome in children (1983) (2)
Bacterial Colonization in Point of Use Filters and Deaths in Flint, Michigan. (2019) (2)
Neuroendocrine function in acquired immunodeficiency syndrome. (1991) (2)
350 HTLV III/LAV antibodies in pediatric acquired immune deficiency syndrome (AIDS) (1985) (2)
Newer microbial agents in diarrhea. (1976) (2)
Elevated circulating levels of tumor necrosis factor are associated with progressive encephalopathy in children with AIDS (1989) (2)
Managing early HIV infection (1994) (2)
Toxicities of antiretroviral therapy in children. (2006) (2)
Treating children with HIV infection: what we can do, we should do. (2007) (2)
Hospitalizations Among Children and Youths With Human Immunodeficiency Virus Infection (2004) (2)
Diagnostic Criteria of Pediatric AIDS (1990) (2)
AIDS in our children--who cares for them? (1990) (2)
Fecal incontinence with myocardial infarction. (1979) (2)
Long-term effects of protease-inhibitor-based combination therapy (2004) (1)
83 Polymorphonuclear leucocyte chematactic defects in children with sickle cell anemia (1983) (1)
Acquired Immune Deficiency Syndrome (AIDS)—A Pediatric Perspective (1983) (1)
Human Immunodeficiency Virus Type 1 Counseling and Testing Program in the Prenatal Setting (1995) (1)
Intrapartum inoculation of herpes simplex virus. (1982) (1)
The Greater Metropolitan Medical Alumni Council (GMMAC) (2013) (1)
PREVENTION OF TRANSFUSION-ACQUIRED CYTOMEGALOVIRUS INFECTION IN THE NEWBORN USING FROZEN RECONSTITUTED BLOOD (1984) (1)
HAART in HIV-infected children: One decade later (2009) (1)
The ‘Mere Civility’ of Equality Law and Compelled-Speech Quandaries (2020) (1)
332 Clinical experience with a native intrvenous immune globulin (1985) (1)
Analysis of ritonavir for the treatment of HIV disease in children: abstract and commentary. (1998) (1)
Familial C3b/C4b inactivator defect in two siblings with recurrent bacterial infections (1982) (1)
'State Inaction,' Equal Protection, and Religious Resistance to LGBT Rights (2015) (1)
Growth and CD4 patterns of adolescents living with perinatally acquired HIV worldwide, a CIPHER cohort collaboration analysis (2022) (1)
Detection of rare cells expressing HTLV-III in primary lymphoid tissue from infected individuals using a highly sensitive in situ hybridization method (1986) (1)
Controversial techniques in allergy treatment. (1983) (1)
Immune function during growth hormone therapy. (1990) (1)
176 In-vitro effect of hepatitis B vaccine on T-lymphocyte subpopulations (1983) (1)
470 Spectrum of thymic aplasia (1988) (1)
Resident Perspectives on Palliative Care at an Urban Teaching Hospital (2021) (1)
Plasma zinc and copper in primary and secondary immunodeficiency disorders (1983) (1)
Lukumi at Twenty: A Legacy of Uncertainty for Religious Liberty and Animal Welfare Laws (2013) (1)
349 Pathology of the thymus in pediatric acquired immune deficiency syndrome (AIDS) (1985) (0)
Acknowledgment of Reviewers (2003) (0)
Maternal Factors Influencing Perinatal Transmission of HIV Infection (1990) (0)
Letter: Not all children are magpies. (1975) (0)
Pediatric AIDS. (1987) (0)
On the historical origins of HIV-1 (MN) and (RF). (1992) (0)
Free Exercise (Dis)Honesty (2019) (0)
On the historical origins of HIV-1 (MN) and (RF). (1992) (0)
659 Non-caseating sarcoid-linked granulomas of spleen in a 51Y/O female with pan-hypogammaglobulinemia (2000) (0)
IMMUNE DYSFUNCTION IN CHILDREN WITH ACQUIRED IMMUNE DEFICIENCY SYNDROME (1984) (0)
Not All Children Are Magpies (1975) (0)
Epidemiology and natural history of pediatric HIV infection (1992) (0)
Nutriyion intervention strategies for infants and children followed for medical care at children's hospital AIDS program, Newark, New Jersey, USA (1997) (0)
SINUSITIS IN 180 CHILDREN INFECTED WITH HUMAN IMMUNODEFICIENCY VIRUS (1998) (0)
An adolescent with history of chronic sinusitis and asthma (2007) (0)
The Public Meaning of RFRA versus Legislators' Understanding of RLPA: A Response to Professor Laycock (2014) (0)
Obamacare, RFRA, and the Perils of Legislative History (2014) (0)
, G immunoglobulin A antibodies . immunodeficiency virus-specific Enzyme immunoassay for detection of human (0)
Evaluation and management of early HIV infection. (1994) (0)
Efficacy of condoms as barriers to HSV-2 and gonorrhea: on in vitro model [abstract] (1981) (0)
The Born-Again Champion of Conscience (Book Review) (2015) (0)
ANTIBODIES TO HUMAN T-CELL LEUKEMIA VIRUS (HTLV) IN CHILDREN WITH ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) (1984) (0)
Care needs of HIV-infected children at New Jersey Children's Hospital (1992) (0)
Combining touch with technique: fusing technology with the art of medicine (2018) (0)
Persistent HTLVIII/LAV infection of brain in children with AIDS and AIDS related complex (ARC) [abstract] (1986) (0)
Subject Index Vol. 11, 2004 (2004) (0)
Cefamandole nafate therapy of skin and soft tissue infections in children (1979) (0)
Acrodermatitis enteropathica, immunodeficiency, and zinc. (1978) (0)
Relationships of Blood Lead Concentrations to Vitamin D, Season of Year, Sunlight Exposure, and Linear Growth in Children (2020) (0)
92 Effects on neutrophil chemiliminescence by various antibiotics and indomethacin (1983) (0)
Epidemiology of Cervical Cancer (1976) (0)
Chapter 17 Immunologic disorders (1989) (0)
The 'Sheet Sign'-Reply (1984) (0)
When should we treat children with HIV? Quando tratar as crianÁas com HIV? (2006) (0)
A Regrettable Invitation to 'Constitutional Resistance,' Renewed Confusion Over Religious Exemptions, and the Future of Free Exercise (2016) (0)
Children with HIV infection. Dilemmas in management. (1989) (0)
Doric Columns Are Not Falling: Wedding Cakes, the Ministerial Exception, and the Public-Private Distinction (2015) (0)
CLINICAL AND LABORATORY STUDIES IN HOUSEHOLD CONTACTS OF PEDIATRIC AIDS CASES (1984) (0)
Pneumonitis In Acquired Immune Deficiency Syndrome (Aids) (2019) (0)
Contents Vol. 11, 2004 (2004) (0)
Long-term effects of protease-inhibitor-based combination therapy. Authors' reply (2004) (0)
Research shows AZT therapy reduces mother-child AIDS transmission. (1994) (0)
Grand Theory or Discrete Proposal? Religious Accommodations and Health Related Harms (2016) (0)
In the Court of Koppelman: Motion for Reconsideration (2020) (0)
Global temporal changes in the proportion of children with advanced disease at the start of combination antiretroviral therapy in an era of changing criteria for treatment initiation (2018) (0)
Neonatal hyperbilirubinemia, phototherapy and risk of autism (2005) (0)
Relationships between the use of second-generation antipsychotics and changes in total cholesterol levels in children and adolescents perinatally infected with HIV. (2010) (0)
Short report T cell subsets and disease progression after total lymphoid irradiation in chronic progressive multiple sclerosis (0)
Pediatric AIDS--Johns Hopkins grand rounds. (1993) (0)
Release of zinc from disposable coils during hemodialysis (1981) (0)
Familial complement c 3b complement c 4b inactivator defect in 2 siblings with recurrent bacterial infections (1982) (0)
A CONSULTATIVE PRACTICE IN PEDIATRIC INFECTIOUS DISEASES (1984) (0)
Arteriopathy in Children with Acquired Immune Deficiency Syndrome (1987) (0)
Clinical outcome and survival time in a cohort of HIV-infected children with atypical mycobacterial infection. ♦ 697 (1997) (0)
Primary and Acquired Immunodeficiency Disorders (2011) (0)
Infant Growth After In Utero Exposure to Zidovudine—Reply (1999) (0)
African-American Infants Human Immunodeficiency Virus Type 1 to Influences Perinatal Transmission of of the CC-Chemokine Receptor 5 Gene A Polymorphism in the Regulatory Region (2013) (0)
Sinusitis in Children Infected with HIV: A Retrospective Review of 180 cases 820 (1998) (0)

This paper list is powered by the following services:

Other Resources About James Oleske

en.wikipedia.org

What Schools Are Affiliated With James Oleske?

James Oleske is affiliated with the following schools:

James Oleske's Academic­Influence.com Rankings